Phaarmasia Limited (BOM:523620)
118.70
-1.26 (-1.05%)
At close: Feb 12, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 810.36 million as of February 13, 2026. Its market cap has increased by 152.55% in one year.
Market Cap
810.36M
Enterprise Value
806.06M
Revenue
449.06M
Ranking
n/a
PE Ratio
4.57
Stock Price
118.70
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 810.36M, an increase of 5,814.09%. That is a compound annual growth rate of 15.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 810.36M | 5.29% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 966.18M |
| Source Natural Foods and Herbal Supplements | 863.51M |
| Zenith Drugs | 831.72M |
| Makers Laboratories | 812.19M |
| Accretion Pharmaceuticals | 760.33M |
| Amwill Health Care | 714.13M |
| Shelter Pharma | 697.57M |
| Asston Pharmaceuticals | 689.55M |